Lysyl Oxidase and the Tumor Microenvironment.

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Extracellular Matrix Biology

Background:

• Lysyl oxidase (LOX) enzymes are copper-dependent oxidases essential for collagen and elastin cross-linking.
• LOX activity is vital for maintaining the structural integrity of the extracellular matrix (ECM).
• Dysregulation of LOX is implicated in various diseases, including cancer, atherosclerosis, and fibrosis.

Purpose of the Study:

• To review current research on the multifaceted roles of LOX in cancer.
• To elucidate the mechanisms by which LOX influences the tumor microenvironment.
• To discuss the involvement of LOX in tumorigenesis and metastasis.

Main Methods:

• Literature review of recent studies on LOX and cancer.
• Analysis of research investigating LOX expression and function in various cancer types.
• Synthesis of data on LOX-mediated ECM remodeling and its impact on cancer progression.

Main Results:

• LOX is frequently overexpressed in numerous cancers, often correlating with tumor progression and metastasis.
• Evidence suggests both oncogenic and tumor-suppressive roles for LOX, depending on the cancer type and context.
• LOX significantly impacts tumor microenvironment remodeling, influencing cellular behavior and disease outcome.

Conclusions:

• LOX plays a complex and context-dependent role in cancer development and progression.
• Understanding LOX's mechanisms in the tumor microenvironment is critical for developing targeted therapies.
• Further research is needed to fully delineate the dual roles of LOX in tumorigenesis and metastasis.